adagrasib
mirati
['lcsm,(-blcsm)', 'krystal-1', 'sclc', 'nsclc']
#asco22 #lcsm krystal-1 study by dr. a spira et al. activity of novel kras g12c inhibitor adagarsib ph-2 registrational study in patients w kras g12c pre-treated nsclc 
Assistant Professor, Thoracic Oncologist, University of Minnesota | Masonic Cancer Center